Top

Supportive Care in Cancer

Published in:

01-08-2016 | Original Article

Engaging Patients as Partners in Developing Patient-Reported Outcome Measures in Cancer—A Review of the Literature

Authors: Natasha Camuso, Prerna Bajaj, Deborah Dudgeon, Gunita Mitera

Published in: Supportive Care in Cancer | Issue 8/2016

Abstract

Purpose

Tools to collect patient-reported outcome measures (PROMs) are frequently used in the healthcare setting to collect information that is most meaningful to patients. Due to discordance among how patients and healthcare providers rank symptoms that are considered most meaningful to the patient, engagement of patients in the development of PROMs is extremely important. This review aimed to identify studies that described how patients are involved in the item generation stage of cancer-specific PROM tools developed for cancer patients.

Methods

A literature search was conducted using keywords relevant to PROMs, cancer, and patient engagement. A manual search of relevant reference lists was also conducted. Inclusion criteria stipulated that publications must describe patient engagement in the item generation stage of development of cancer-specific PROM tools. Results were excluded if they were duplicate findings or non-English.

Results

The initial search yielded 230 publications. After removal of duplicates and review of publications, 6 were deemed relevant. Fourteen additional publications were retrieved through a manual search of references from relevant publications. A total of 13 unique PROM tools that included patient input in item generation were identified. The most common method of patient engagement was through qualitative interviews or focus groups.

Conclusions

Despite recommendations from international groups and the emphasized importance of incorporating patient feedback in all stages of development of PROMs, few unique tools have incorporated patient input in item generation of cancer-specific tools. Moving forward, a framework of best practices on how to best engage patients in developing PROMs is warranted to support high-quality patient-centered care.

U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health (2009) Guidance for industry. use in medical product development to support labeling claims. Rockville, MD, Patient-reported outcome measures

Johnson C, Aaronson N, Blazeby JM, Bottomley A, Fayer P, Koller M, Kulis D, Ramage J, Sprangers M, Velikova G, Young T, Group obotEQoL (2011) EORTC Quality of Life Group—Guidelines for Developing Questionnaire Modules. 4th edn

Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD (2009) Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. Value Health 12(8):1075–1083. doi:10.1111/j.1524-4733.2009.00603.x CrossRefPubMed

Cheville AL, Basford JR, Dos Santos K, Kroenke K (2014) Symptom burden and comorbidities impact the consistency of responses on patient-reported functional outcomes. Arch Phys Med Rehabil 95(1):79–86. doi:10.1016/j.apmr.2013.08.009 CrossRefPubMed

Macquart-Moulin G, Viens P, Bouscary ML, Genre D, Resbeut M, Gravis G, Camerlo J, Maraninchi D, Moatti JP (1997) Discordance between physicians’ estimations and breast cancer patients’ self-assessment of side-effects of chemotherapy: an issue for quality of care. Br J Cancer 76(12):1640–1645CrossRefPubMedPubMedCentral

Brunelli C, Costantini M, Di Giulio P, Gallucci M, Fusco F, Miccinesi G, Paci E, Peruselli C, Morino P, Piazza M, Tamburini M, Toscani F (1998) Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manag 15(3):151–158CrossRef

Stephens RJ, Hopwood P, Girling DJ, Machin D (1997) Randomized trials with quality of life endpoints: are doctors’ ratings of patients’ physical symptoms interchangeable with patients’ self-ratings? Qual Life Res Int J Qual Life Asp Treat Care Rehab 6(3):225–236

Wagner LI, Robinson D Jr, Weiss M, Katz M, Greipp P, Fonseca R, Cella D (2012) Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction. J Pain Symptom Manag 43(6):1094–1104. doi:10.1016/j.jpainsymman.2011.06.019 CrossRef

Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Spile M, Sjogren P (2001) Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manag 21(3):189–196CrossRef

10.

Stromgren AS, Groenvold M, Sorensen A, Andersen L (2001) Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating. Acta Anaesthesiol Scand 45(9):1080–1085CrossRefPubMed

11.

Garcia SF, Rosenbloom SK, Beaumont JL, Merkel D, Von Roenn JH, Rao D, Cella D (2012) Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16). Value Health 15(1):183–190. doi:10.1016/j.jval.2011.08.1739 CrossRefPubMed

12.

Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Quality Life Outcomes 1:79. doi:10.1186/1477-7525-1-79 CrossRef

13.

Lent L, Hahn E, Eremenco S, Webster K, Cella D (1999) Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales. Acta Oncol 38(6):695–702CrossRefPubMed

14.

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al. (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol Off J Am Soc Clin Oncol 11(3):570–579

15.

FACIT.org (2010) FACIT.org Questionnaires. FACIT.org. http://www.facit.org/FACITOrg/Questionnaires. Accessed November 9 2015

16.

Flynn KE, Jeffery DD, Keefe FJ, Porter LS, Shelby RA, Fawzy MR, Gosselin TK, Reeve BB, Weinfurt KP (2011) Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)). Psycho-Oncology 20(4):378–386. doi:10.1002/pon.1738 CrossRefPubMed

17.

Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, Weinfurt KP (2013) Development of the NIH PROMIS Sexual Function and Satisfaction measures in patients with cancer. J Sex Med 10(Suppl 1):43–52. doi:10.1111/j.1743-6109.2012.02995.x CrossRefPubMedPubMedCentral

18.

Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ (1996) Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Investigative Dermatol 107(5):707–713CrossRef

19.

Bates AS, Davis CR, Takwale A, Knepil GJ (2013) Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review. British J Dermatol 168(6):1187–1194. doi:10.1111/bjd.12269 CrossRef

20.

Lee EH, Klassen AF, Nehal KS, Cano SJ, Waters J, Pusic AL (2013) A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population. J Am Acad Dermatol 69(2):e59–e67. doi:10.1016/j.jaad.2012.09.017 CrossRefPubMed

21.

Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 19(3):210–216CrossRefPubMed

22.

Morgan M, McCreedy R, Simpson J, Hay RJ (1997) Dermatology quality of life scales—a measure of the impact of skin diseases. British J Dermatol 136(2):202–206CrossRef

23.

Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB (2006) Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg 32(7):924–934 discussion 934. doi:10.1111/j.1524-4725.2006.32197.x CrossRefPubMedPubMedCentral

24.

Rhee JS, Matthews BA, Neuburg M, Burzynski M, Nattinger AB (2005) Creation of a quality of life instrument for nonmelanoma skin cancer patients. Laryngoscope 115(7):1178–1185. doi:10.1097/01.mlg.0000166177.98414.5e CrossRefPubMedPubMedCentral

25.

Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB (2006) Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg 8(5):314–318. doi:10.1001/archfaci.8.5.314 CrossRefPubMedPubMedCentral

26.

Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB (2007) The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope 117(3):399–405. doi:10.1097/MLG.0b013e31802e2d88 CrossRefPubMedPubMedCentral

27.

Burdon-Jones D, Thomas P, Baker R (2010) Quality of life issues in nonmetastatic skin cancer. British J Dermatol 162(1):147–151. doi:10.1111/j.1365-2133.2009.09469.x CrossRef

28.

Mathias SD, Chren MM, Colwell HH, Yim YM, Reyes C, Chen DM, Fosko SW (2014) Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome development of the first disease-specific patient-reported outcome questionnaires. JAMA Dermatol 150(2):169–176. doi:10.1001/jamadermatol.2013.5870 CrossRefPubMed

29.

Cano SJ, Browne JP, Lamping DL, Roberts AH, McGrouther DA, Black NA (2006) The Patient Outcomes of Surgery-Head/Neck (POS-head/neck): a new patient-based outcome measure. J Plast Reconstr Aesthet Surg JPRAS 59(1):65–73CrossRefPubMed

30.

Kleinman L, Benjamin K, Viswanathan H, Mattera MS, Bosserman L, Blayney DW, Revicki DA (2012) The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy. Qual Life Res Int J Qual Life Asp Treat Care Rehab 21(7):1255–1266. doi:10.1007/s11136-011-0034-1 CrossRef

31.

Senn B, Gafner D, Happ MB, Eicher M, Mueller MD, Engberg S, Spirig R (2011) The unspoken disease: symptom experience in women with vulval neoplasia and surgical treatment: a qualitative study. European J Cancer Care 20(6):747–758. doi:10.1111/j.1365-2354.2011.01267.x CrossRef

32.

Senn B, Mueller MD, Hasenburg A, Blankenstein T, Kammermann B, Hartmann A, Donovan H, Eicher M, Spirig R, Engberg S (2012) Development of a postsurgical patient-reported outcome instrument for women with vulvar neoplasia. Oncol Nurs Forum 39(6):E489–E498. doi:10.1188/12.onf.e489-e498 CrossRefPubMed

33.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed

34.

Cancer EOfRaTo EORTC Quality of Life. EORTC Quality of Life Department. http://groups.eortc.be/qol/eortc-qlq-c30. Accessed November 9 2015

35.

Portfolio CJ (2012) Navigation: a guide to implementing best practices in person-centred care. ON, Toronto

Title: Engaging Patients as Partners in Developing Patient-Reported Outcome Measures in Cancer—A Review of the Literature
Authors: Natasha Camuso
Prerna Bajaj
Deborah Dudgeon
Gunita Mitera
Publication date: 01-08-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 8/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3151-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2016

Demographic, clinical, psychosocial, and environmental correlates of objectively assessed physical activity among breast cancer survivors

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial

The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy

Access to oral care before hematopoietic stem cell transplantation: understand to improve

Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit

Dynasplint Trismus System exercises for trismus secondary to head and neck cancer: a prospective explorative study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer